<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04574154</url>
  </required_header>
  <id_info>
    <org_study_id>191-19000</org_study_id>
    <nct_id>NCT04574154</nct_id>
  </id_info>
  <brief_title>Regional Anesthesia in THR - Comparing the Analgesic Efficacy of Fascia Iliaca Block and Erector Spinae Plane Block</brief_title>
  <acronym>PTA-ALR</acronym>
  <official_title>Regional Anesthesia in THR - Comparing Analgesic Efficacy of Fascia Iliaca Block and Erector Spinae Plane Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Papa Giovanni XXIII Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Papa Giovanni XXIII Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      THR (Total Hip Replacement) can be very painful and regional anesthesia is very effective in&#xD;
      reducing postoperative pain. Fascia Iliaca Block (FIB) and Erector Spinae Plane Block (ESPB)&#xD;
      are indirect approaches to the lumbar plexus that resulted to be very promising for THR.&#xD;
      However, no studies investigated the analgesic superiority of either FIB or ESPB. In our&#xD;
      study the investigators compare FIB and ESPB in terms of pain relief expressed as morphine&#xD;
      consumption in the first 24 hours after primary THR.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 20, 2020</start_date>
  <completion_date type="Actual">August 21, 2021</completion_date>
  <primary_completion_date type="Actual">May 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>morphine</measure>
    <time_frame>24 hours</time_frame>
    <description>milligrams of morphine consumed in the first postoperative day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>perceived postoperative pain: Numeric Rating Scale (NRS)</measure>
    <time_frame>24 hs</time_frame>
    <description>11 point scale from 0 = &quot;no pain&quot; to 10 = &quot;worst imaginable pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>perceived postoperative pain: Numeric Rating Scale (NRS)</measure>
    <time_frame>48 hours</time_frame>
    <description>11 point scale from 0 = &quot;no pain&quot; to 10 = &quot;worst imaginable pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>48 hours</time_frame>
    <description>occurrence of nausea/vomiting, ileum, pruritus and urinary retention in the first 48 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of persistent pain at 1 month after surgery</measure>
    <time_frame>1 month</time_frame>
    <description>evaluation of NRS (numeric rating Scale; 11 point scale from 0 = &quot;no pain&quot; to 10 = &quot;worst imaginable pain&quot;)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>FIB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ultrasound guided Fascia Iliaca Block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESPB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ultrasound guided Erector Spinae Plane Block</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FIB</intervention_name>
    <description>FIB with ultrasound: Ropivacaine 0.5% 40 ml</description>
    <arm_group_label>FIB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ESPB</intervention_name>
    <description>ESPB (L4) with ultrasound: Ropivacaine 0.5% 40 ml</description>
    <arm_group_label>ESPB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>spinal anesthesia</intervention_name>
    <description>bupivacaine 0,5% 2.2 ml</description>
    <arm_group_label>ESPB</arm_group_label>
    <arm_group_label>FIB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  primary THR&#xD;
&#xD;
          -  informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  allergies to study drugs&#xD;
&#xD;
          -  spinal anesthesia contraindicated&#xD;
&#xD;
          -  kidney failure&#xD;
&#xD;
          -  epilepsy, psychiatric disease, neurologic deficits&#xD;
&#xD;
          -  revision surgery&#xD;
&#xD;
          -  neuropathies in the lumbar area&#xD;
&#xD;
          -  no informed consent&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  alcohol/opioid abuse&#xD;
&#xD;
          -  emergency surgery/intensive care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aast Papa Giovanni Xxiii</name>
      <address>
        <city>Bergamo</city>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2020</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Papa Giovanni XXIII Hospital</investigator_affiliation>
    <investigator_full_name>Dario Bugada</investigator_full_name>
    <investigator_title>MD PhD, principal investigator, attending anesthesiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

